Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics

Here is how Immunocore performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for Immunocore here>>> Shares of Immunocore have returned -7.2% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term. Geographic Revenue- United States: $64.09 million versus $59.44 million es ...